Tag: Illumina

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

IBM Jumps Into Liquid Biopsy Market

| August 8, 2016 | 0 Comments

If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a lab-on-a-chip technology that can separate particles at the nanoscale. The ability to do that can […]

Continue Reading

Adopting NGS for tumor profiling: Accessible sequencing. Flexible solutions.

| February 19, 2016 | 0 Comments

Date: Wednesday, February 24 Time: 9:00 AM (PT) Speaker: Claire Ray Associate Product Manager Oncology, Illumina Abstract: Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while simultaneously helping to preserve precious samples. In this webinar, you will learn more about the advantages that NGS offers over traditional methods, and be introduced to the newest, cost effective […]

Continue Reading